Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner R, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson M, Wirth A, Tsang R, Prica A, Major A, Smith S, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng A, Koenig J, Constine LS, Casulo C, Sakthivel G, Baron J, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh A, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel G, Brennan B, Penn A, Senchenko MA, Volchkov EV, Reeves M, Hoppe B, Terezakis S, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes E, Lee D, Doo NW, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar A, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS. Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses. Blood Adv. 2026 Aug 11; 10(15):5338-5347.

Oselinsky KM, Hill EB, Ostendorf DM, Pan Z, Bing K, Wayland LT, Simpson C, Clark KC, Sandoval A, Thomas EA, Marker RJ, Kabos P, MacLean PS, Catenacci VA. Exploring the Feasibility, Acceptability, and Safety of a 4:3 Intermittent Fasting Weight Loss Program Among Stage I-III Breast Cancer Survivors With Overweight or Obesity: Protocol for a 6-Month Proof-of-Concept Feasibility Trial. JMIR Res Protoc. 2026 Jul 23; 15:e86281.

Morganti S, Kim SE, Jin Q, Cha J, Zeigler JE, Newman AB, Kirkner GJ, Snow C, Zheng Y, Vincuilla J, Parker T, Buehler RM, Bychkovsky BL, Dibble KE, Sella T, Ruddy KJ, Rosenberg SM, Collins LC, Peppercorn J, Schapira L, Borges VF, Guzman-Arocho YD, Come SE, Warner E, Poorvu PD, Lambertini M, Curigliano G, Hughes ME, Mittendorf EA, King TA, Lin NU, Garber JE, Tayob N, Tolaney SM, Partridge AH, Lynce F. Outcomes and treatment patterns in germline BRCA1/2 carriers from two matched cohort studies. JNCI Cancer Spectr. 2026 Jul 07; 10(4).

Gorbatov ML, Arizpe A, David EA, Liu L, Cockburn M, Farias AJ. Racial and ethnic disparities in receipt of guideline-concordant treatment for early-stage non-small cell lung cancer. Cancer Causes Control. 2026 Jul 01; 37(7).

Zhang R, Chavana A, Shi Y, Zhou B, Ugarte V, Sun B, Guo B, Kazemifar S, Echeverria A, Ludwig M, Owrangi A. Dosimetric comparison of high dose rate interstitial brachytherapy and stereotactic body radiotherapy as alternative treatment methods for advanced-stage cervical cancer. Biomed Phys Eng Express. 2026 Jun 19; 12(3).

Tesch ME, Zheng Y, Guzman-Arocho YD, Collins LC, Heng YJ, Tayob N, Rosenberg SM, Ruddy KJ, Tamimi RM, Schapira L, Peppercorn J, Borges V, Come SE, Snow C, Winer EP, Mittendorf EA, Partridge AH. Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor-Positive Breast Cancer. Clin Cancer Res. 2026 Jun 01; 32(11):2268-2278.

Bazhenova L, Ismaila N, Durm G, Freeman-Daily J, Horinouchi H, MacVicar GR, Mishra DR, Pellini B, Schenk EL, Singh N, Leighl NB. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1. J Clin Oncol. 2026 06 20; 44(18):e101-e112.

Lula LJ, Costa R, Franssen AJPM, Huang L, Özgür EG, Barreda CF, Domjan M, Weedle R, Jasovic C, Trabalza Marinucci B, Rebei M, Ghasemi K, Moreira AL, Ryan R, Bekiroglu GN, Young V, Gomez T, de Loos ER, Fitzmaurice GJ, Bennett KE, Mancini M, Varela G, Savu C, Mariolo AV, Bunn P, Stupnik T, Furak J, D'Andrilli A, Jimenez M, Cerfolio R, Bolca C, Brunelli A, Rami-Porta R, Petersen RH, Rendina EA. European analysis of patients with early-stage lung adenocarcinoma and invasive pathologic features who underwent lobectomy versus segmentectomy. J Thorac Cardiovasc Surg. 2026 Aug; 172(2):413-421.e4.

Spratt DE, Srinivas S, Adra N, Ahmed B, An Y, Bitting R, Chapin B, Cheng HH, Cho SY, D'Amico AV, Desai N, Dorff T, Eastham JA, Farrington TA, Gao X, Gupta S, Ippolito JE, Karnes RJ, Kishan AU, Kuettel MR, Lang JM, Lee D, Lotan T, McDonald A, Morgan TM, Pessoa R, Rais-Bahrami S, Roach M, Robin T, Rosenfeld S, Scarpato KR, Seibert T, Shabsigh A, Szmulewitz R, Teply BA, Tward J, Valicenti R, VanderWeele D, Wong JK, Kovach E, Freedman-Cass D. NCCN Guidelines® Insights: Prostate Cancer, Version 5.2026. J Natl Compr Canc Netw. 2026 May; 24(5):140-149.

Maslana KE, Burns RD, Bai Y, Playdon MC, Estabrooks PA, Saviers-Steiger C, Dunston ER, Galyean P, Kimball ER, Zickmund SL, Hansen PA, Ulrich CM, LaStayo PC, Steinberg D, Noren CS, Finch A', Seckinger L, Oza S, Brownson KE, Coletta AM. The association of an exercise and rehabilitation clinical workflow algorithm on sedentary behavior and performance status from time of breast cancer diagnosis and throughout care. Breast Cancer Res Treat. 2026 Apr 17; 217(2).